Effect of lactobacillus plantarum strain K21 on high-fat diet-fed obese mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Wu, Chien Chen ^a   Weng, Wei Lien ^a   Lai, Wen Lin ^b,c   Tsai, Hui Ping ^a   Liu, Wei Hsien ^a   Lee, Meng Hwan ^d   Tsai, Ying Chieh ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Agricultural Technology Research Institute   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE SALT; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; TRIACYLGLYCEROL;

ADIPOGENESIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; BIFIDOBACTERIUM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CLOSTRIDIUM PERFRINGENS; COLONY FORMING UNIT; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOWN REGULATION; DYSLIPIDEMIA; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; LACTOBACILLUS PLANTARUM; LIPID DIET; LIPID HOMEOSTASIS; LIPID STORAGE; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; WEIGHT GAIN; WESTERN DIET;

EID: 84924390289     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/391767     Document Type: Article

References (38)

1. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, "The metabolic syndrome", The Lancet, vol. 365, no. 9468, pp. 1415-1428, 2005.
2. G. Marchesini, M. Brizi, A. M. Morselli-Labate et al., "Association of nonalcoholic fatty liver disease with insulin resistance", The American Journal of Medicine, vol. 107, no. 5, pp. 450-455, 1999.
3. C. E. Ndumele, K. Nasir, R. D. Conceiçao, J. A. M. Carvalho, R. S. Blumenthal, and R. D. Santos, "Hepatic steatosis, obesity, and themetabolic syndrome are independently and additively associated with increased systemic inflammation", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 8, pp. 1927-1932, 2011.
4. A. M. Caricilli and M. J. A. Saad, "Gut microbiota composition and its effects on obesity and insulin resistance", Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 4, pp. 312-318, 2014.
5. V. Tremaroli and F. Bäckhed, "Functional interactions between the gut microbiota and host metabolism", Nature, vol. 489, no. 7415, pp. 242-249, 2012.
6. R. E. Ley, "Obesity and the human microbiome", Current Opinion in Gastroenterology, vol. 26, no. 1, pp. 5-11, 2010.
7. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiomewith increased capacity for energy harvest", Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
8. P. J. Turnbaugh, F. Bäckhed, L. Fulton, and J. I. Gordon, "Dietinduced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome", Cell Host and Microbe, vol. 3, no. 4, pp. 213-223, 2008.
9. P. D. Cani and N. M. Delzenne, "Gut microflora as a target for energy andmetabolic homeostasis", Current Opinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 6, pp. 729-734, 2007.
10. T. Arora, S. Singh, and R. K. Sharma, "Probiotics: interaction with gut microbiome and antiobesity potential", Nutrition, vol. 29, no. 4, pp. 591-596, 2013.
11. FAO/WHO, "Health and nutritional properties of probiotics in food including powder milk with live lactic: report of a joint FAO/WHO expert consultation on acid bacteria expert consultation on evaluation of health and nutritional properties of probitics in food including powder milk with live lactic acid bacteria", Tech. Rep., 2001.
12. J. Behnsen, E. Deriu, M. Sassone-Corsi, and M. Raffatellu, "Probiotics: properties, examples, and specific applications", Cold SpringHarbor Perspectives in Medicine, vol. 3, no. 3, Article ID a010074, 2013.
13. A. Iacono, G. M. Raso, R. B. Canani, A. Calignano, and R. Meli, "Probiotics as an emerging therapeutic strategy to treatNAFLD: focus on molecular and biochemical mechanisms", Journal of Nutritional Biochemistry, vol. 22, no. 8, pp. 699-711, 2011.
14. A. M. O'Hara and F. Shanahan, "Mechanisms of action of probiotics in intestinal diseases", The Scientific World Journal, vol. 7, pp. 31-46, 2007.
15. M. P. Dashkevicz and S. D. Feighner, "Development of a differential medium for bile salt hydrolase-active Lactobacillus spp.", Applied and EnvironmentalMicrobiology, vol. 55, no. 1, pp. 11-16, 1989.
16. A. D. Danielson, E. R. Peo Jr., K. M. Shahani, A. J. Lewis, P. J. Whalen, and M. A. Amer, "Anticholesteremic property of Lactobacillus acidophilus yogurt fed to mature boars", Journal of Animal Science, vol. 67, no. 4, pp. 966-974, 1989.
17. Y. Y. Chen, M. H. Lee, C. C. Hsu, C. L. Wei, and Y. C. Tsai, "Methyl cinnamate inhibits adipocyte differentiation via activation of the CaMKK2-AMPK pathway in 3T3-L1 preadipocytes", Journal of Agricultural and Food Chemistry, vol. 60, no. 4, pp. 955-963, 2012.
18. P. D. Cani, S. Possemiers, T. Van De Wiele et al., "Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability", Gut, vol. 58, no. 8, pp. 1091-1103, 2009.
19. C.-H. Chiu, T.-Y. Lu, Y.-Y. Tseng, and T.-M. Pan, "The effects of Lactobacillus-fermentedmilk on lipid metabolism in hamsters fed on high-cholesterol diet", AppliedMicrobiology and Biotechnology, vol. 71, no. 2, pp. 238-245, 2006.
20. A. K. Patel, R. R. Singhania, A. Pandey, and S. B. Chincholkar, "Probiotic bile salt hydrolase: current developments and perspectives", Applied Biochemistry and Biotechnology, vol. 162, no. 1, pp. 166-180, 2010.
21. O. Gavrilova, M. Haluzik, K. Matsusue et al., "Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass", The Journal of Biological Chemistry, vol. 278, no. 36, pp. 34268-34276, 2003.
22. P. D. Cani, R. Bibiloni, C. Knauf et al., "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice", Diabetes, vol. 57, no. 6, pp. 1470-1481, 2008.
23. P. Brun, I. Castagliuolo, V. Di Leo et al., "Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis", The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 292, no. 2, pp. G518-G525, 2007.
24. Y. Ritze, G. Bárdos, A. Claus et al., "Lactobacillus rhamnosusGG Protects against non-alcoholic fatty liver disease in mice", PLoS ONE, vol. 9, no. 1, Article ID e80169, 2014.
25. D. Y. Park, Y. T. Ahn, S. H. Park et al., "Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity", PLoS ONE, vol. 8, no. 3, Article IDe59470, 2013.
26. Y. Huang and Y. Zheng, "The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells", British Journal of Nutrition, vol. 103, no. 4, pp. 473-478, 2010.
27. L. Aronsson, Y. Huang, P. Parini et al., "Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)", PLoS ONE, vol. 5, no. 9, Article ID e13087, 2010.
28. N. Takemura, T. Okubo, and K. Sonoyama, "Lactobacillus plantarumstrain No. 14 reduces adipocyte size in mice fed highfat diet", Experimental Biology and Medicine (Maywood), vol. 235, no. 7, pp. 849-856, 2010.
29. J.-H. Kang, S.-I. Yun, M.-H. Park, J.-H. Park, S.-Y. Jeong, and H.-O. Park, "Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice", PLoS ONE, vol. 8, no. 1, Article ID e54617, 2013.
30. H. Y. Huang, M. Korivi, C.-H. Tsai, J.-H. Yang, and Y.-C. Tsai, "Supplementation of Lactobacillus plantarum K68 and fruitvegetable ferment along with high fat-fructose diet attenuates metabolic syndrome in rats with insulin resistance", Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 943020, 2013.
31. X. Ma, J. Hua, and Z. Li, "Probiotics improve high fat dietinduced hepatic steatosis and insulin resistance by increasing hepatic NKT cells", Journal of Hepatology, vol. 49, no. 5, pp. 821-830, 2008.
32. M. Million, E. Angelakis, M. Paul, F. Armougom, L. Leibovici, and D. Raoult, "Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals", Microbial Pathogenesis, vol. 53, no. 2, pp. 100-108, 2012.
33. P. A. Bron, D. Molenaar, W. M. De Vos, and M. Kleerebezem, "DNA micro-array-based identification of bile-responsive genes in Lactobacillus plantarum", Journal of Applied Microbiology, vol. 100, no. 4, pp. 728-738, 2006.
34. E. Morán-Salvador, M. López-Parra, V. García-Alonso et al., "Role for PPARgamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts", The FASEB Journal, vol. 25, no. 8, pp. 2538-2550, 2011.
35. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli, "Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors", Cell, vol. 68, no. 5, pp. 879-887, 1992.
36. S. Wagnerberger, A. Spruss, G. Kanuri et al., "Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model", Journal of Nutritional Biochemistry, vol. 24, no. 3, pp. 531-538, 2013.
37. C. Hofmann, K. Lorenz, S. S. Braithwaite et al., "Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance", Endocrinology, vol. 134, no. 1, pp. 264-270, 1994.
38. T. Arora, J. Anastasovska, G. Gibson et al., "Effect of Lactobacillus acidophilusNCDC 13 supplementation on the progression of obesity in diet-induced obese mice", British Journal of Nutrition, vol. 108, no. 8, pp. 1382-1389, 2012.